1. Beetler DJ, Di Florio DN, Bruno KA, Ikezu T, March KL, Cooper LT, Jr., et al., Extracellular vesicles as personalized medicine. Mol Aspects Med, 2023. 91: 101155. [
DOI:10.1016/j.mam.2022.101155] [
PMID] [
]
2. Lopes D, Lopes J, Pereira-Silva M, Peixoto D, Rabiee N, Veiga F, et al., Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine. Military Medical Research, 2023. 10(1): 19. [
DOI:10.1186/s40779-023-00453-z] [
PMID] [
]
3. Chu X, Hou M, Li Y, Zhang Q, Wang S, Ma J, Extracellular vesicles in endometriosis: role and potential. Frontiers in Endocrinology, 2024. 15. [
DOI:10.3389/fendo.2024.1365327] [
PMID] [
]
4. Wagner M, Hicks C, El-Omar E, Combes V, El-Assaad F, The Critical Role of Host and Bacterial Extracellular Vesicles in Endometriosis. Biomedicines, 2024. 12.(11) [
DOI:10.3390/biomedicines12112585] [
PMID] [
]
5. Mosquera-Heredia MI, Morales LC, Vidal OM, Barceló E, Silvera-Redondo C, Vélez JI, et al., Exosomes: Potential Disease Biomarkers and New Therapeutic Targets. Biomedicines, 2021. 9.(8) [
DOI:10.3390/biomedicines9081061] [
PMID] [
]
6. Wang Y, Ma H, Zhang X, Xiao X, Yang Z, The Increasing Diagnostic Role of Exosomes in Inflammatory Diseases to Leverage the Therapeutic Biomarkers. J Inflamm Res, 2024. 17: 5005-5024.
7. Skuratovskaia D, Vulf M, Khaziakhmatova O, Malashchenko V, Komar A, Shunkin E, et al., Exosome Limitations in the Treatment of Inflammatory Diseases. Current Pharmaceutical Design, 2021. 27(28): 3105-3121. [
DOI:10.2174/1381612826666201210120444] [
PMID]
8. Fan M-H, Pi J-K, Zou C-Y, Jiang Y-L, Li Q-J, Zhang X-Z, et al., Hydrogel-exosome system in tissue engineering: A promising therapeutic strategy. Bioactive Materials, 2024. 38: 1-30. [
DOI:10.1016/j.bioactmat.2024.04.007] [
PMID] [
]
9. Lee KWA, Chan LKW, Hung LC, Phoebe LKW, Park Y, Yi KH, Clinical Applications of Exosomes: A Critical Review. Int J Mol Sci, 2024. 25. (14) [
DOI:10.3390/ijms25147794] [
PMID] [
]